Marc H Hedrick insider trades

Open-market stock purchases and sales by Marc H Hedrick, Chief Executive Officer at Cerenome, Inc, from SEC Form 4 filings since Feb 5, 2010.

Track record: 100% of 9 scored buys are up 5% or more since purchase, averaging +97%.

Recent trades

DateStockTradeValue
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
May 14, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Apr 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Apr 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Feb 25, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jan 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—

Companies traded

  • CNSY Cerenome, Inc: other filings, last Oct 1, 2026
  • PSTV Plus Therapeutics, Inc: 12 buys, 1 sale, last Jul 1, 2026
  • CTYX Cytori Therapeutics, Inc: other filings, last Jul 25, 2018
  • CYTX Cytori Therapeutics, Inc: 17 buys, last Jun 15, 2016

Get free alerts when Marc H Hedrick files a new trade →